Epigallocatechin‐3‐gallate, a DYRK1A inhibitor, rescues cognitive deficits in <scp>D</scp>own syndrome mouse models and in humans

2013275 citationsJournal Article

Authors

We conclude that EGCG is a promising therapeutic tool for cognitive enhancement in DS, and its efficacy may depend of Dyrk1A inhibition.

Published in: Molecular Nutrition & Food Research

Volume 58, Issue 2, pp. 278-288

Field-Weighted Citation Impact: 23.81